{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:45:44Z","timestamp":1772865944537,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1124\/jpet.114.214197","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:17:50Z","timestamp":1396570670000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment with the 3-Ketoacyl-CoA Thiolase Inhibitor Trimetazidine Does Not Exacerbate Whole-Body Insulin Resistance in Obese Mice"],"prefix":"10.1016","volume":"349","author":[{"given":"John R.","family":"Ussher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Keung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Koves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Lopaschuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga R.","family":"Ilkayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory S.","family":"Wagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdip S.","family":"Jaswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Muoio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.","family":"Lopaschuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.214197_bib1","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s00125-006-0338-9","article-title":"Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3","volume":"49","author":"An","year":"2006","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.114.214197_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1172\/JCI37048","article-title":"Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans","volume":"119","author":"Anderson","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.214197_bib3","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1161\/CIR.0b013e31828987e5","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.214197_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/db11-1060","article-title":"Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr\u2212\/\u2212 mice","volume":"61","author":"Bates","year":"2012","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.214197_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2337\/db08-1078","article-title":"Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance","volume":"58","author":"Bruce","year":"2009","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.214197_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1755-5922.2011.00275.x","article-title":"Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans","volume":"30","author":"Bucci","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"10.1124\/jpet.114.214197_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramide-centric view of insulin resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.114.214197_bib8","doi-asserted-by":"crossref","first-page":"16480","DOI":"10.1073\/pnas.0706794104","article-title":"Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity","volume":"104","author":"Choi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.214197_bib9","doi-asserted-by":"crossref","unstructured":"Ciapponi A, Pizarro R, Harrison J (2005) Trimetazidine for stable angina. Cochrane Database Syst Rev (4):CD003614.","DOI":"10.1002\/14651858.CD003614.pub2"},{"key":"10.1124\/jpet.114.214197_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diabetes.50.1.123","article-title":"Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats","volume":"50","author":"Dobbins","year":"2001","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.214197_bib11","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1161\/01.RES.0000129255.19569.8f","article-title":"Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation","volume":"94","author":"Dyck","year":"2004","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.214197_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmet.2005.01.006","article-title":"A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes","volume":"1","author":"Finck","year":"2005","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.114.214197_bib13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2006.03.060","article-title":"A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure","volume":"48","author":"Fragasso","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.114.214197_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation\u2014a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.114.214197_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.214197_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/db12-0259","article-title":"Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice","volume":"62","author":"Keung","year":"2013","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.214197_bib17","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2337\/db10-0427","article-title":"Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system","volume":"60","author":"Kovalik","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.214197_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.114.214197_bib19","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.214197_bib20","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/01.RES.0000086964.07404.A5","article-title":"Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase","volume":"93","author":"Lopaschuk","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.214197_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cmet.2012.04.010","article-title":"Lipid-induced mitochondrial stress and insulin action in muscle","volume":"15","author":"Muoio","year":"2012","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.114.214197_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1152\/ajplegacy.1967.212.4.804","article-title":"Effect of pressure development on oxygen consumption by isolated rat heart","volume":"212","author":"Neely","year":"1967","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.114.214197_bib23","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1074\/jbc.M109.032888","article-title":"Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control","volume":"284","author":"Noland","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.214197_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1124\/jpet.114.214197_bib25","doi-asserted-by":"crossref","first-page":"E1459","DOI":"10.1152\/ajpendo.00018.2012","article-title":"Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance","volume":"303","author":"Samokhvalov","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.114.214197_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.114.214197_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.214197_bib28","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI46405","article-title":"Mitochondrial dysfunction in patients with primary congenital insulin resistance","volume":"121","author":"Sleigh","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.214197_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cmet.2006.11.005","article-title":"Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling","volume":"4","author":"Steinberg","year":"2006","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.114.214197_bib30","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1073\/pnas.1206868109","article-title":"Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity","volume":"109","author":"Timmers","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.214197_bib31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.108.778019","article-title":"Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy","volume":"118","author":"Tuunanen","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.214197_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.111.246371","article-title":"Pyridine nucleotide regulation of cardiac intermediary metabolism","volume":"111","author":"Ussher","year":"2012","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.214197_bib33","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.1152\/ajpendo.00009.2009","article-title":"Role of the atypical protein kinase Czeta in regulation of 5\u2032-AMP-activated protein kinase in cardiac and skeletal muscle","volume":"297","author":"Ussher","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.114.214197_bib34","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/db09-1293","article-title":"Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption","volume":"59","author":"Ussher","year":"2010","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.214197_bib35","first-page":"9","article-title":"Clinical implications of energetic problems in cardiovascular disease","volume":"32","author":"Ussher","year":"2006","journal-title":"Heart and Metabolism"},{"key":"10.1124\/jpet.114.214197_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cvr\/cvn130","article-title":"The malonyl CoA axis as a potential target for treating ischaemic heart disease","volume":"79","author":"Ussher","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.114.214197_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/cvr\/cvs129","article-title":"Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury","volume":"94","author":"Ussher","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.114.214197_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nm1383","article-title":"CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK","volume":"12","author":"Watt","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/jpet.114.214197_bib39","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1073\/pnas.0707060104","article-title":"Mitochondrial dysfunction due to long-chain acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.214197_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI114857","article-title":"Skeletal muscle metabolism is a major determinant of resting energy expenditure","volume":"86","author":"Zurlo","year":"1990","journal-title":"J Clin Invest"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.214197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:23:38Z","timestamp":1739985818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524186958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0022356524186958"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.214197","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with the 3-Ketoacyl-CoA Thiolase Inhibitor Trimetazidine Does Not Exacerbate Whole-Body Insulin Resistance in Obese Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.214197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}